Skip to content

Treatment of Subclinical Hypothyroidism in participants aged between 20 to 45 years with Iodium and Individualized Homoeopathic Medicine and studying their temperament

Assessing the temperament and effectiveness of Iodium and Individualized Homoeopathic Medicine in the management of Subclinical Hypothyroidism A comparative study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103537
Enrollment
60
Registered
2026-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

Intervention1: Iodium and Individualized Homoeopathic Medicine: Among 2 groups Iodium will be given to the subjects having Iodium symptoms and remaining will be given individualized homoeopathic medic
Better: open air, cool temperature, movement 6 Feeling of heart squeezed with palpitation on slightest exertion 7 Appetite increased alternating with loss of appetite. 8 Irregular menses Control Int

Sponsors

Dr Chaithra v
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects who are willing to participate as volunteers and sign the written informed consent 2 Subjects of age group 20 to 45years 3 Subjects newly diagnosed with Subclinical Hypothyroidism with blood investigations of elevated TSH levels 4.2 micro international units per milliliter to 10 micro international units per milliliter and normal FT4 level

Exclusion criteria

Exclusion criteria: 1 Pregnant and lactating women 2 Subjects receiving treatment for systemic illness 3 Subjects receiving treatment from other systems of medicine for the same complaint or any other complaint.

Design outcomes

Primary

MeasureTime frame
Complete relief in symptoms of subclinical hypothyroidism and normal TSH value and a normal free T4Timepoint: By the end of 12 weeks

Secondary

MeasureTime frame
Reduction of symptoms and Reduction in TSH and Free T4 valueTimepoint: By the end 24 weeks

Countries

India

Contacts

Public ContactDr Chaithra v

Government homoeopathic medical college and hospital

drvijayalaxmi.angadi@gmail.com9448989575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026